Back to Journals » ClinicoEconomics and Outcomes Research » Volume 6

Different strategies and cost-effectiveness in the treatment of primary open angle glaucoma

Authors Ting N, Li Yim J, Ng J

Received 24 October 2013

Accepted for publication 11 June 2014

Published 4 December 2014 Volume 2014:6 Pages 523—530

DOI https://doi.org/10.2147/CEOR.S30697

Checked for plagiarism Yes

Review by Single-blind

Peer reviewer comments 2


Naomi SJ Ting,1 James FT Li Yim,2 Jia Y Ng2,3

1Hull Royal Infirmary, Hull, UK; 2Department of Ophthalmology, University Hospital Ayr, South Ayrshire, UK; 3Faculty of Medicine, University of Glasgow, Glasgow, UK

Abstract: Glaucoma is the second highest cause of blindness worldwide with an estimated half of the glaucoma population unaware of their disease. To date, intraocular pressure is the most important modifiable risk factor and lowering it has been proven to reduce progression of visual field loss associated with glaucoma. Different strategies are available to lower intraocular pressure and include medical, laser, or surgical treatment in the form of topical or systemic medications, argon or selective laser trabeculoplasty, and glaucoma drainage surgery such as trabeculectomy, deep sclerectomy, or other drainage devices. The effectiveness of these treatments has been well documented however their cost-effectiveness between the developed world and third world remains unclear.

Keywords: intraocular pressure, sclerectomy, trabeculectomy, trabeculoplasty, open angle glaucoma

Creative Commons License This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

Download Article [PDF]  View Full Text [HTML][Machine readable]